title: [Effectiveness of Dialectical Behavior Therapy (DBT) in an outpatient clinic for borderline personality disorders - impact of medication use and treatment costs].
abstract: OBJECTIVE
  Investigation of the clinical effectiveness of dialectical behavioral therapy in a day clinic setting (DBT-DC) for borderline personality disorders (BPD), and impact of medication and daily costs.
  
  
  METHODS
  In a prospective, naturalistic, open and uncontrolled design BPD patients were enclosed in a 12-week DBT-DC. This DBT-program was certified by the German network of DBT. We collected data from the Symptom Checklist (SCL-90), the Beck Depression Inventory (BDI) and the Borderline Symptom List 95 (BSL-95) in the first and at the end of the 11th week. The concomitant medication and its changes were described.
  
  
  RESULTS
  31 cases were included (9 drop-outs: 29 %). The average age was 33.3 years (18 - 52, SD = 10.6). 21 females and one male completed the program. There was no relationship between changes of BDI, SCL-90 and BSL-95 scores (p < 0.001) and medication (and its alteration). The BDI scores improved by 50.8 % (p < 0.001), the SCL-90 by 42.9 % (p < 0.01) and the BSL-95 by 48.4 % (p < 0.001). The power was 0.99 (α = 0.05), the effect size was 1.41. In our setting the daily costs showed a reduction of about 6500 € per case compared to an inpatient DBT. Medications played no significant role for improvement.
  
  
  CONCLUSIONS
  For the first time a partial remission for BPD patients after 12 weeks has been shown to be achieved in a DBT-DC setting. DBT-DC reduces the primary costs of BPD compared to a specific inpatient therapy.
authors.affiliation: Vivantes Wenckebach-Klinikum, Psychiatrie, Psychotherapie und Psychosomatik/ Gerontopsychiatrie.
authors.forename: Christoph
authors.initials: C
authors.lastname: Richter
authors.affiliation: Vivantes Wenckebach-Klinikum, Psychiatrie, Psychotherapie und Psychosomatik/ Gerontopsychiatrie.
authors.forename: Brigitte
authors.initials: B
authors.lastname: Heinemann
authors.affiliation: Vivantes Wenckebach-Klinikum, Psychiatrie, Psychotherapie und Psychosomatik/ Gerontopsychiatrie.
authors.forename: Mathias
authors.initials: M
authors.lastname: Kehn
authors.affiliation: Vivantes Wenckebach-Klinikum, Psychiatrie, Psychotherapie und Psychosomatik/ Gerontopsychiatrie.
authors.forename: Bruno
authors.initials: B
authors.lastname: Steinacher
mesh_terms: D000293:Adolescent; D000328:Adult; D001883:Borderline Personality Disorder / Q000175:diagnosis / Q000191:economics* / Q000523:psychology / Q000628:therapy*; D015928:Cognitive Behavioral Therapy / Q000191:economics* / Q000379:methods*; D003131:Combined Modality Therapy / Q000191:economics; D017046:Cost Savings / Q000191:economics; D003631:Day Care, Medical / Q000191:economics* / Q000379:methods*; D005260:Female; D005858:Germany; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009313:National Health Programs / Q000191:economics*; D011446:Prospective Studies; D011619:Psychotropic Drugs / Q000191:economics / Q000627:therapeutic use; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D011619:Psychotropic Drugs